Malta - English - Medicines Authority

baxter healthcare limited - calcium chloride dihydrate; phenylalanine; histidine; arginine; alanine; threonine; tryptophan; tyrosine; valine; glycine; methionine; isoleucine; lysine; magnesium chloride hexahydrate; serine; leucine; proline; sodium chloride; sodium lactate - solution for peritoneal dialysis - calcium chloride dihydrate 184 mg/l; phenylalanine 570 mg/l; histidine 714 mg/l; arginine 1071 mg/l; alanine 951 mg/l; threonine 646 mg/l; tryptophan 270 mg/l; tyrosine 300 mg/l; valine 1393 mg/l; glycine 510 mg/l; methionine 850 mg/l; isoleucine 850 mg/l; lysine 955 mg/l; magnesium chloride hexahydrate 51 mg/l; serine 510 mg/l; leucine 1020 mg/l; proline 595 mg/l; sodium chloride 5380 mg/l; sodium lactate 4480 mg/l - blood substitutes and perfusion solutions

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lamberts healthcare ltd - l-phenylalanine - oral capsule - 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - l-phenylalanine - oral capsule - 100mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - l-phenylalanine - oral capsule - 25mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - l-phenylalanine - not applicable - 50mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - l-phenylalanine - oral capsule - 500mg

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

21st century products sdn. bhd. - l-phenylalanine -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

nutricia ltd - l-alanine - powder - 1gram/1gram

United States - English - NLM (National Library of Medicine)

baxter healthcare corporation - lysine acetate (unii: ttl6g7liwz) (lysine - unii:k3z4f929h6), leucine (unii: gmw67qnf9c) (leucine - unii:gmw67qnf9c), phenylalanine (unii: 47e5o17y3r) (phenylalanine - unii:47e5o17y3r), valine (unii: hg18b9yrs7) (valine - unii:hg18b9yrs7), histidine (unii: 4qd397987e) (histidine - unii:4qd397987e), isoleucine (unii: 04y7590d77) (isoleucine - unii:04y7590d77), methionine (unii: ae28f7pnpl) (methionine - unii:ae28f7pnpl), threonine (unii: 2zd004190s) (threonine - unii:2zd004190s), tryptophan (unii: 8d - lysine 1.18 g in 100 ml - 15% clinisol - sulfite-free (amino acid) injection pharmacy bulk package is indicated as an adjunct in the offsetting of nitrogen loss or in the treatment of negative nitrogen balance in patients where: (1) the alimentary tract cannot or should not be used, (2) gastrointestinal absorption of protein is impaired, or (3) metabolic requirements for protein are substantially increased, as with extensive burns. hypersensitivity to one or more amino acids severe liver disease or hepatic coma anuria metabolic disorders involving impaired nitrogen utilization

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - histidine (unii: 4qd397987e) (histidine - unii:4qd397987e), isoleucine (unii: 04y7590d77) (isoleucine - unii:04y7590d77), leucine (unii: gmw67qnf9c) (leucine - unii:gmw67qnf9c), lysine acetate (unii: ttl6g7liwz) (lysine - unii:k3z4f929h6), methionine (unii: ae28f7pnpl) (methionine - unii:ae28f7pnpl), phenylalanine (unii: 47e5o17y3r) (phenylalanine - unii:47e5o17y3r), threonine (unii: 2zd004190s) (threonine - unii:2zd004190s), tryptophan (unii: 8duh1n11bx) (tryptophan - unii:8duh1n11bx), valine (unii - histidine 0.25 g in 100 ml - 5.4% nephramine® (essential amino acid injection) is indicated for adult and pediatric use, in conjunction with other measures, to provide nutritional support for uremic patients, particularly when oral nutrition is infeasible or impractical. see warnings, precautions, pediatric use , special precautions in pediatric patients , and dosage and administration . nephramine® is contraindicated in patients with severe, uncorrected electrolyte and acid-base imbalance, hyperammonemia, decreased (subcritical) circulating blood volume, inborn errors of amino acid metabolism, or hypersensitivity to one or more amino acids present in the solution.